GO:0004303 estradiol 17-beta-dehydrogenase [NAD(P)+] activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004303 describes the enzymatic activity that interconverts estradiol-17-beta and estrone using NAD+ or NADP+ as the acceptor, a central step in estrogen metabolism.
• The activity is carried out by 17-beta-hydroxysteroid dehydrogenase (17-beta-HSD) enzymes, which are expressed in steroidogenic tissues and in peripheral tissues such as breast, placenta, and skeletal muscle.
• 17-beta-HSD activity is developmentally regulated; in preimplantation rat and mouse embryos, its activity changes markedly during early cleavage stages.
• Cytokines such as interleukin-1 and tumor necrosis factor-alpha modulate 17-beta-HSD activity in MCF-7 breast cancer cells, linking inflammation to local estrogen production.
• In teleost fish, steroidogenesis including 17-beta-HSD activity is under endocrine control, providing comparative insight into estrogen regulation.
• The enzyme does not require zinc for full activity, distinguishing it from some other dehydrogenases.
Description
GO:0004303, estradiol 17-beta-dehydrogenase [NAD(P)+] activity, is a molecular function that catalyzes the reversible conversion of estradiol-17-beta to estrone, with concomitant reduction of NAD(P)+ to NAD(P)H. This reaction is a key switch in estrogen biology because estradiol-17-beta is the most potent estrogen, whereas estrone is a much weaker estrogen; thus the activity directly controls the local balance of estrogenic potency in tissues. The enzyme belongs to the short-chain dehydrogenase/reductase family and is widely known as 17-beta-hydroxysteroid dehydrogenase (17-beta-HSD). Researchers study this activity to understand how peripheral tissues regulate estrogen action independently of gonadal production, a process implicated in breast cancer, endometrial physiology, and developmental biology. The activity is also relevant to comparative endocrinology, as steroidogenic pathways in teleost fish rely on similar enzymatic steps. Because the reaction can use either NAD+ or NADP+, the cellular redox state influences which direction is favored, making the enzyme a metabolic sensor of sorts.
estradiol 17-beta-dehydrogenase [NAD(P)+] activity At A Glance
| GO ID | GO:0004303 |
|---|---|
| GO term | estradiol 17-beta-dehydrogenase [NAD(P)+] activity |
| Ontology | molecular_function |
| Synonym | 17-beta-HSD activity; estradiol dehydrogenase activity; estrogen 17-oxidoreductase activity; 17-beta-estradiol dehydrogenase activity |
| Major function | Catalyzes the reversible oxidation of estradiol-17-beta to estrone using NAD+ or NADP+ as acceptor |
| Reaction direction | Reversible; can also reduce estrone to estradiol-17-beta using NAD(P)H |
| Cofactor | NAD+ or NADP+ (both accepted) |
| Subcellular location | Endoplasmic reticulum and cytoplasm (typical for steroidogenic enzymes) |
| Tissue distribution | Steroidogenic tissues (placenta, ovary, testis) and peripheral tissues (breast, skeletal muscle) |
What Is GO:0004303?
In my own words, GO:0004303 describes the catalytic activity of an enzyme that removes a hydride from the 17-beta position of estradiol-17-beta, transferring it to NAD+ or NADP+ to form NAD(P)H and releasing a proton, while the steroid is oxidized to estrone. The reaction is reversible, so the same enzyme can reduce estrone back to estradiol-17-beta using NAD(P)H. The definition explicitly notes that either NAD+ or NADP+ can serve as the acceptor, meaning the enzyme is not strictly cofactor-specific. This activity is synonymous with 17-beta-HSD, 17-beta-estradiol dehydrogenase, and estrogen 17-oxidoreductase, reflecting its role in estrogen interconversion.
Why Is estradiol 17-beta-dehydrogenase [NAD(P)+] activity Important in Cell Biology?
GO:0004303 is important because it controls the local concentration of the most potent estrogen, estradiol-17-beta, and thus influences estrogen receptor signaling in both normal physiology and disease. In breast cancer, intratumoral 17-beta-HSD activity can drive proliferation by maintaining estradiol levels. In reproduction, the activity is essential for preimplantation embryo development, as shown by changing enzyme levels in rat and mouse embryos. In metabolic tissues such as skeletal muscle, exercise modulates sex steroid hormones including estradiol, and 17-beta-HSD activity may contribute to local hormone balance. The enzyme also serves as a model for understanding short-chain dehydrogenase/reductase catalysis, especially since it functions without zinc. Finally, comparative studies in teleost fish reveal conserved regulatory principles of steroidogenesis.
• Controls the potency of estrogen action by interconverting estradiol-17-beta and estrone.
• Implicated in breast cancer biology through local estrogen production in MCF-7 cells.
• Essential for early embryo development, with dynamic activity changes in preimplantation embryos.
• Modulated by cytokines, linking inflammation to estrogen metabolism.
• Relevant to exercise physiology and skeletal muscle steroid hormone balance.
• Provides a comparative model for steroidogenesis in teleost fish.
• Functions independently of zinc, unlike some other dehydrogenases.
• Target for understanding endocrine disruption by xenobiotics such as zearalenone.
• Potential biomarker for choriocarcinoma and placental steroidogenesis.
• Enables researchers to study redox-dependent estrogen signaling.
Molecular Mechanism of estradiol 17-beta-dehydrogenase [NAD(P)+] activity
Substrate binding and orientation
In simple terms: The enzyme grabs estradiol and holds it in the right position for a chemical change.
The enzyme binds estradiol-17-beta in a hydrophobic pocket that positions the 17-beta hydroxyl group near the catalytic residues. This orientation allows stereospecific hydride transfer to NAD(P)+. The binding site accommodates both estradiol and estrone, enabling reversibility.
Hydride transfer and cofactor recycling
In simple terms: A hydrogen atom is moved from estradiol to NAD(P)+, turning estradiol into estrone.
The catalytic mechanism involves direct hydride transfer from the C17-beta hydroxyl of estradiol to the nicotinamide ring of NAD(P)+, forming NAD(P)H and estrone. The reaction is reversible, so NAD(P)H can donate hydride back to estrone to regenerate estradiol. The enzyme accepts both NAD+ and NADP+, although the preferred cofactor may vary by isoform and tissue.
Cofactor specificity and redox sensing
In simple terms: The enzyme can use two different helper molecules, so it adapts to the cell's energy state.
Because the activity uses either NAD+ or NADP+, the intracellular ratio of NAD+/NADH versus NADP+/NADPH influences the direction of the reaction. This makes the enzyme sensitive to metabolic and redox conditions. The lack of a zinc requirement distinguishes it from some other dehydrogenases and suggests a different catalytic strategy.
Regulation by cytokines and hormones
In simple terms: Inflammation and hormones can turn the enzyme up or down.
In MCF-7 breast cancer cells, cytokines such as interleukin-1 and tumor necrosis factor-alpha interact to regulate 17-beta-HSD activity, linking inflammatory signaling to local estrogen production. In skeletal muscle, exercise alters sex steroid hormone levels, potentially affecting 17-beta-HSD activity. In teleost fish, steroidogenesis is under endocrine control, indicating conserved regulatory pathways.
Developmental and tissue-specific expression
In simple terms: The enzyme's activity changes with age and differs between tissues.
In preimplantation rat and mouse embryos, 17-beta-HSD activity changes dynamically, suggesting a role in early development. In choriocarcinoma cells, both enzymatic activity and mRNA species for 17-beta-HSD have been characterized, showing tissue-specific expression patterns. These findings indicate that the activity is not constitutive but is tightly regulated in a spatiotemporal manner.
Key Genes Involved in GO:0004303 estradiol 17-beta-dehydrogenase [NAD(P)+] activity
The following genes and proteins are directly associated with estradiol 17-beta-dehydrogenase [NAD(P)+] activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HSD17B1 | Encodes 17-beta-HSD type 1, primarily catalyzes reduction of estrone to estradiol | Breast cancer and endometriosis models |
| HSD17B2 | Encodes 17-beta-HSD type 2, primarily oxidizes estradiol to estrone | Estrogen inactivation in peripheral tissues |
| HSD17B3 | Encodes 17-beta-HSD type 3, testicular enzyme for testosterone synthesis | Male sexual differentiation |
| HSD17B4 | Peroxisomal multifunctional enzyme with 17-beta-HSD activity | D-bifunctional protein deficiency |
| HSD17B5 | Also known as AKR1C3, catalyzes 17-beta-HSD reactions | Prostate and breast cancer |
| HSD17B7 | Involved in cholesterol and steroid synthesis | Developmental studies |
| HSD17B8 | Part of the 17-beta-HSD family | Basic enzymology |
| HSD17B10 | Mitochondrial 17-beta-HSD, also involved in neurodegeneration | Alzheimer's disease models |
| HSD17B11 | Retinal short-chain dehydrogenase | Retinoid metabolism |
| HSD17B12 | Involved in fatty acid elongation and steroid metabolism | Cancer metabolism |
| HSD17B13 | Liver-specific 17-beta-HSD, associated with fatty liver disease | NAFLD models |
| HSD17B14 | Expressed in brain and gonads | Neurosteroidogenesis |
| CYP19A1 | Aromatase, produces estradiol from testosterone | Breast cancer and steroidogenesis |
| ESR1 | Estrogen receptor alpha, mediates estradiol signaling | Breast cancer and endometrial cancer |
| ESR2 | Estrogen receptor beta | Tissue-specific estrogen action |
| IL1B | Interleukin-1 beta, regulates 17-beta-HSD activity | Inflammation and cancer |
| TNF | Tumor necrosis factor, modulates 17-beta-HSD activity | Inflammation and cancer |
| ZEB1 | Zinc finger E-box binding homeobox 1, potential regulator | Epithelial-mesenchymal transition |
How Is estradiol 17-beta-dehydrogenase [NAD(P)+] activity Regulated?
The activity of estradiol 17-beta-dehydrogenase [NAD(P)+] is regulated at multiple levels. In MCF-7 breast cancer cells, cytokines such as interleukin-1 and tumor necrosis factor-alpha interact to modulate enzyme activity, suggesting that inflammatory pathways influence local estrogen metabolism. Exercise also affects sex steroid hormones in skeletal muscle, potentially altering 17-beta-HSD activity. In teleost fish, steroidogenesis is under endocrine control, with gonadotropins and other hormones regulating the pathway. Additionally, the redox state of the cell, reflected in NAD+/NADH and NADP+/NADPH ratios, can shift the reaction direction because the enzyme uses both cofactors. Developmental stage also matters: in preimplantation embryos, activity changes dynamically, indicating developmental regulation. Finally, xenobiotics such as zearalenone can affect steroidogenic enzymes in the porcine intestinal tract, highlighting environmental modulation.
estradiol 17-beta-dehydrogenase [NAD(P)+] activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HSD17B1 | Breast cancer, endometriosis | MCF-7 knockout and overexpression |
| HSD17B2 | Estrogen-dependent cancers | T47D cell line with point mutations |
| HSD17B3 | Male pseudohermaphroditism | Knock-in mouse models |
| HSD17B10 | Alzheimer's disease, neurodegeneration | Neuronal knockout models |
| HSD17B13 | Non-alcoholic fatty liver disease | Hepatocyte overexpression |
Breast cancer and local estrogen production
In breast cancer, intratumoral 17-beta-HSD activity can maintain high levels of estradiol-17-beta, promoting estrogen receptor-positive cell proliferation. Studies in MCF-7 cells show that cytokines regulate this activity, linking inflammation to tumor estrogen production. The enzyme is therefore a potential target for endocrine therapy.
Reproductive disorders and embryo development
17-beta-HSD activity is essential for early embryo development, as demonstrated by changing activity in preimplantation rat and mouse embryos. Dysregulation may contribute to implantation failure or early pregnancy loss. In choriocarcinoma, both activity and mRNA species have been characterized, suggesting a role in placental pathology.
Metabolic and skeletal muscle effects
Exercise modulates sex steroid hormones in skeletal muscle, and 17-beta-HSD activity may influence local estrogen balance, affecting muscle metabolism and adaptation. This has implications for understanding how physical activity affects hormone-related diseases.
Xenobiotic disruption and comparative endocrinology
Zearalenone, a mycotoxin with estrogenic activity, affects xenobiotic-metabolizing enzymes in the porcine intestinal tract, potentially interfering with 17-beta-HSD activity. In teleost fish, steroidogenesis is regulated by environmental and endocrine factors, providing a model for endocrine disruption.
From estradiol 17-beta-dehydrogenase [NAD(P)+] activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of 17-beta-HSD activity affect estrogen levels? | CRISPR knockout of HSD17B1 in MCF-7 cells |
| How do point mutations alter substrate specificity? | Point mutation knock-in of HSD17B2 in HEK293 cells |
| Can we tag the enzyme to track localization? | Knock-in of fluorescent tag at HSD17B1 locus |
| What is the effect of overexpression on proliferation? | Overexpression of HSD17B5 in breast cancer cell lines |
| How does developmental stage affect activity? | Embryonic stem cell differentiation models |
| Does cytokine treatment regulate enzyme activity? | Cytokine stimulation of MCF-7 cells with knockout controls |
How to Study the estradiol 17-beta-dehydrogenase [NAD(P)+] activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled substrate assay | Enzymatic conversion rate | Cofactor preference and kinetics |
| RNA-seq | mRNA expression of HSD17B isoforms | Tissue-specific expression profiling |
| Western blot | Protein levels of 17-beta-HSD | Validation of knockout or overexpression |
| CRISPR screen | Genes affecting estrogen-dependent growth | Breast cancer cell models |
| Immunofluorescence | Subcellular localization | Endoplasmic reticulum vs cytoplasm |
| Mass spectrometry | Steroid metabolite quantification | Metabolomics of estrogen pathway |
| qPCR | Transcript levels after cytokine treatment | Inflammation studies |
| Embryo culture assay | Activity changes during development | Preimplantation embryo models |
Enzymatic activity assays
Direct measurement of 17-beta-HSD activity using radiolabeled estradiol or estrone and NAD(P)+/NAD(P)H, followed by thin-layer chromatography or HPLC separation. This method quantifies the conversion rate and cofactor preference.
RNA-seq and transcriptomics
RNA sequencing can reveal expression levels of HSD17B isoforms and splice variants across tissues and conditions, helping to correlate mRNA species with enzymatic activity.
Proteomics and western blotting
Western blotting with isoform-specific antibodies detects protein levels, while mass spectrometry-based proteomics can identify post-translational modifications that regulate activity.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that modify 17-beta-HSD activity or estrogen-dependent phenotypes, using reporters or cell viability as readouts.
How CRISPR Can Be Used to Study GO:0004303 estradiol 17-beta-dehydrogenase [NAD(P)+] activity
Knockout
CRISPR knockout of HSD17B genes can abolish 17-beta-HSD activity, allowing researchers to test its role in estrogen-dependent proliferation, embryo development, and metabolism. For example, knocking out HSD17B1 in MCF-7 cells reduces estradiol production and may inhibit tumor growth.
Point Mutation
Introducing point mutations in catalytic residues or cofactor-binding sites can dissect the mechanism of hydride transfer and cofactor specificity. Such models help determine which residues are essential for NAD+ versus NADP+ usage.
Knock-in
Knock-in of epitope tags or fluorescent proteins at the endogenous HSD17B locus enables real-time tracking of enzyme localization and dynamics without overexpression artifacts. This is useful for studying subcellular trafficking.
Overexpression
Overexpression of HSD17B isoforms in cell lines can mimic pathological states such as breast cancer, where elevated enzyme activity increases local estradiol. This approach helps identify downstream effects on estrogen receptor signaling.
How EDITGENE Supports estradiol 17-beta-dehydrogenase [NAD(P)+] activity Research
Researchers studying estradiol 17-beta-dehydrogenase [NAD(P)+] activity-related genes often need to determine whether a candidate gene is causally involved in estrogen metabolism, developmental processes, or disease. EDITGENE provides a comprehensive suite of CRISPR services to create precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for estradiol 17-beta-dehydrogenase [NAD(P)+] activity research.
Frequently Asked Questions About estradiol 17-beta-dehydrogenase [NAD(P)+] activity
What is estradiol 17-beta-dehydrogenase [NAD(P)+] activity?
It is the enzymatic activity that converts estradiol-17-beta to estrone using NAD+ or NADP+ as the acceptor, encoded by GO:0004303.
What genes are involved in estradiol 17-beta-dehydrogenase [NAD(P)+] activity?
The HSD17B family, including HSD17B1, HSD17B2, HSD17B3, and others, encode enzymes with this activity.
How is 17-beta-HSD activity regulated?
It is regulated by cytokines, hormones, developmental stage, and redox state, as shown in MCF-7 cells and embryos.
What diseases are associated with 17-beta-HSD activity?
Breast cancer, reproductive disorders, and metabolic conditions have been linked to altered activity.
Does 17-beta-HSD require zinc for activity?
No, full enzymatic activity occurs in the absence of zinc.
Can 17-beta-HSD use both NAD+ and NADP+?
Yes, the activity can use either NAD+ or NADP+ as the acceptor.
How does exercise affect 17-beta-HSD activity?
Exercise modulates sex steroid hormones in skeletal muscle, potentially influencing local 17-beta-HSD activity.
What is the role of 17-beta-HSD in embryo development?
Activity changes dynamically in preimplantation embryos, suggesting a role in early development.
How can I study 17-beta-HSD activity in the lab?
Enzymatic assays, RNA-seq, western blot, and CRISPR screens are common methods.
What model systems are used for 17-beta-HSD research?
MCF-7 breast cancer cells, preimplantation embryos, and teleost fish are used.
Conclusion
GO:0004303, estradiol 17-beta-dehydrogenase [NAD(P)+] activity, is a critical molecular function that governs the balance between potent and weak estrogens. Its regulation by cytokines, developmental cues, and redox state makes it a focal point for understanding estrogen-related physiology and disease. Researchers can leverage CRISPR models to dissect its roles in breast cancer, reproduction, and metabolism, with EDITGENE providing tailored solutions for knockout, point mutation, knock-in, overexpression, and screening studies.
References
- 2. Rajakumar A et al.. 2020. Steroidogenesis and its regulation in teleost-a review.. Fish Physiol Biochem 46(3):803-818 PMID: 31940121
- 3. Murdock GL et al.. 1991. Estradiol 17 beta-dehydrogenase: full enzymatic activity in the absence of zinc.. Biochim Biophys Acta 1076(2):197-202 PMID: 1998720
- 4. Barbieri RL et al.. 1994. 17 beta-Hydroxysteroid dehydrogenase: enzymatic activity and mRNA species in choriocarcinoma cells.. Gynecol Obstet Invest 37(3):210-4 PMID: 8005555
- 5. Duncan LJ et al.. 1994. The interaction of cytokines in regulating oestradiol 17 beta-hydroxysteroid dehydrogenase activity in MCF-7 cells.. J Steroid Biochem Mol Biol 49(1):63-8 PMID: 8003440
- 6. Sato K et al.. 2015. Exercise and sex steroid hormones in skeletal muscle.. J Steroid Biochem Mol Biol 145:200-5 PMID: 24704257
- 7. Gajęcka M et al.. 2016. Activity of Zearalenone in the Porcine Intestinal Tract.. Molecules 22(1) PMID: 28029134
- 8. Wu JT et al.. 1985. Changing 17 beta-hydroxysteroid dehydrogenase activity in preimplantation rat and mouse embryos.. Biol Reprod 32(3):561-6 PMID: 3857941
